Tricida Provides Update on FDA Interactions

    NEXT STORY
    Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST
    PREV STORY
    TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aquinox Pharmaceuticals Announces Third Quarter 2016 Financial Results

    VANCOUVER, British Columbia, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...

    author_avatar
    NASDAQ Market News

    Global Hepatitis B Market Spotlight 2019: GlaxoSmithKline has the Highest Number of Completed Trials for Bepatitis B, with 286 Trials

    author_avatar
    NASDAQ Market News

    The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis

    author_avatar
    NASDAQ Market News